ABSTRACT
ÖZET

Amaç: Kan dolaşımı enfeksiyonları (KDE) hastanelerde mortalitenin önemli nedenlerindendir. Bu enfeksiyonları yönetebilmek için lokal surveyans verileri göz önünde bulundurulmalıdır. Bu çalışmanın amacı; kan dolaşımı enfeksiyonlarında mikrobiyolojik karakteristikleri ve mortalite risk faktörlerini belirlemektir.
Materyal ve Metot: Ocak 2011 ve Haziran 2015 yılları arası hasta ve laboratuvara dayalı aktif prospektif surveyans verileri değerlen-dirildi. Çalışmaya primer kan dolaşımı enfeksiyonu olan hastaların ilk epizodları dahil edildi. Kan dolaşımı enfeksiyonlarını tanımla-mak için CDC tanı kriterleri kullanıldı. Kaydedilen veriler arasında; demografik veriler, altta yatan hastalıklar, invaziv işlemler, ateş (≥38°C) veya hipotermi (<36°C) varığı, etken izolatlar ve antimikrobiyal direnç paternleri, hastalığın başlangıcı sonrası ilk 3 gün içinde uygun antibiyotik kullanımı ile 14 gün içindeki mortalite yer almaktadır.
Bulgular: Çalışma süresince sağlık bakım ilişkili kan dolaşımı enfeksiyonu olan 373 hasta tanımlandı. Acinetobacter en sık saptanan izolat (%20,4, n=76) olup sonrasında sırasıyla Koagulaz negatif stafilokoklar (KNS) (%19,3, n=72), kandida suşları (%17,2, n=64) ve Klebsiella suşları (%11, n=41) saptandı. Acinetobacter suşları arasında çok ilaca direnç oranı %98,7 idi. Metisilin direnci S.aureus için %66,7 ve KNS için %79,2 bulundu. Genişlemiş spektrumlu beta laktamaz (ESBL) oranı Klebsiella suşlarında %65
) ve E.coli suşlarında %67,9 (19/28) 
Introduction
Bloodstream infections (BSIs) are one of the major health care associated infections in nosocomial setting and associated with significant morbidity and mortality. The causative microorganisms and resistance patterns of isolates vary in different setting and geographic regions 1, 2 . In addition, increasing rate of the resistant microorganisms further complicate the problem and increase the mortality rate. For that reason, it is important to monitor the most frequent isolates and determine their resistance patterns since the early appropriate antimicrobial therapy is crucial to decrease the mortality. Therefore, the performance of active prospective surveillance and careful evaluation of the data regarding these infections are important [1] [2] [3] .
The aim of this study was to evaluate the current epidemiology, isolate distribution and resistance patterns of causative microorganisms, in addition to the mortality risk factors and 14-day outcome after the onset of BSIs.
Material and Method
Patients and Hospital Settings
The present study was conducted in Ankara Numune Training and Research Hospital (ANTRH) in Turkey. Active prospective surveillance data based on patient and laboratory were evaluated from January 2011 to June 2015 in the 1140-bed tertiary care hospital. The data was gathered by the nurses working in infection control committee and infectious disease specialists. The criteria of Centers for Disease Control and Prevention (CDC) case definition was used to define BSIs. The first episode of primary BSIs of the patients ≥18 years from intensive care units and wards were included into the study. However, the patients with polymicrobial BSIs were excluded.
Data Collection
The data including; demographic characteristics, intensive care unit (ICU) stay, underlying conditions (e.g., diabetes mellitus, chronic renal failure, chronic obstructive pulmonary disease (COPD), invasive procedures (central venous catheter (CVC), mechanical ventilator (MV) etc.), support of total parenteral nutrition (TPN), fever (>=38°C) or hypothermia (<36°C), BSI type (CVC related or not), causative isolates and antimicrobial resistance patterns (Multidrug resistance (MDR), extended spectrum beta lactamases (ESBL), methicillin resistance), appropriate antimicrobial therapy within 3 days after the onset of infection, and 14-day outcome after the onset of infection were recorded.
Definitions
Definitions were provided in Table 1 based on the previous studies and guidelines [3] [4] [5] .
Microbiological Tests
Isolate identification and antimicrobial susceptibility tests were performed using a VITEK automated system BioMerieux, Marcy I'Etoile, France). The Clinical and Laboratory Standards Institute (CLSI) criteria were used to determine the resistance or susceptibility Patients with at least has one of the following criteria; 1) Isolation of microorganisms from blood (such as E.coli, Klebsiella spp., Pseudomonas spp., S.aureus, Enterococcus spp., Candida spp, and others) for ≥1 positive culture that was not related to another infection of body sites 2) Patients with one of the following signs that was not related to another infection focus; fever (38°C), chills or hypotension and ≥2 positive different culture results for probable skin contaminant pathogens, such as Coagulase negative Staphylococcus (CoNs)
Laboratory-confirmed central venous catheter-associated bloodstream infections (CVC-BSI) 3 Patients with a CVC had a recognized pathogen isolated from ≥1 percutaneous blood cultures after 48 h of central venous catheterization (unrelated with another infection). The patients should also have at least one of the following signs and symptoms: fever (38°C), chills, or hypotension. With the common skin commensals (e.g., diphtheroids, (CoNs)), the organisms had to have been cultured from ≥2 separate blood cultures
Multidrug resistant bacteria infection 4 An infection due to a Gram-negative bacteria which has a resistance to ≥3 classes of antimicrobial agents Appropriate antimicrobial therapy 5 Administrated drug has in-vitro activity against the causative isolates according to antimicrobial susceptibility test results or administration of the drug within 72 h of the infection onset 14-day mortality Death within 14 days of infection onset to the antimicrobial agents 6 . ESBL production was determined and confirmed using a double-disc synergy test in line with CLSI guidelines 7 .
Variables such as demographic characteristics, etiologic agents, antimicrobial resistance patterns of the isolates, inappropriate antimicrobial therapy and all other possible causes of mortality were identified. Survivors and non-survivors 14 days after the onset of BSI were compared to identify the predictors of the mortality. Continuous variables were described as median (minmax). Chi-square tests were used for categorical variables and Mann Whitney U tests were used for continued variables. Although, bacteremia is reported as second frequent infections in ICU in some studies, it was reported as a most common health care associated infection in a multicenter study performed in our country [9] [10] [11] [12] . It is an important health care problem, since it is frequent and many of the causative microorganisms have developed resistance to the most of the antimicrobials 13 . The present study focused on the identification of the epidemiologic characteristics and antimicrobial resistance patterns (ESBL, MDR etc.) of causative isolates and the predictors of mortality in patients with BSI. We determined the 14 day mortality rate as the main outcome measure and the mortality rate was detected as 37.8%. The median age was significantly higher in fatal cases (68 years) in univariate analysis which was not found as an independent predictor for mortality. Cevik et al. reported that, although statistically insignificant, patient with older age (≥70 years) had higher mortality rate 14 .
We evaluated the impact of underlying conditions on mortality, since the host defenses have an important role in patient outcome. The presence of ≥2 underlying conditions was detected as a significant risk factor for mortality (p = 0.018, OR: 1.98, 95% CI: 1.1-3.4) consistent with the literature 10 . Hypothermia, dialysis and steroid usage were also found as independent predictors of mortality.
When we evaluated causative microorganisms, we determined that Gram negative pathogens were the most common isolates different from the study of Inan et al., who reported S.aureus as a predominant pathogen in CVC related BSI in ICU 1 . The prevalent pathogen was Acinetobacter spp. (20.4%), followed by CoNS and Candida spp. in our study. C.albicans is the most common subspecies in Candida spp. consistent with the literature 15 . Higher mortality rates in Gram-negative BSIs were reported in previous studies than Gram-positive infections 16, 17 . In the present study, similar with the literature, we demonstrated that infections with Gramnegative isolates had significantly higher whereas infections with Gram-positive isolates had significantly lower mortality rates. We thought that the low virulence of CoNS isolates may be the cause of lower mortality rates. BSIs with Acinetobacter spp. and Candida spp. were determined as independent predictors of mortality. In recent years, there has been a noticeable increase in health care associated infections caused by multidrug resistant pathogens 1, 18 . Wide spectrum antibiotic usage (>7 days) prior to the onset of BSI was found in 61.4% of all patients, which may be one of the causes of high resistance rate in our study. It is known that, previous antibiotic usage leads to the selection of resistance pathogens 19 .
Gram-negative bacteria (48.5%, n=181). Acinetobacter spp. was the most common isolates (20.4%, n=76), followed by CoNS (19.3%, n=72) , Candida spp. (17.2%, n=64) and Klebsiella spp. (11%, n=41) (Table 3) . When the causative isolates were compared between years 2014 and 2011, a significant decrease in the frequency of Acinetobacter spp. (15.6%, 15/96 vs 30.1%, 19/63, respectively p = 0.016) was detected. There was no other significant difference between years according to other pathogens.
Of total Acinetobacter spp. isolates, the ratio of multidrug resistance was 98.7%. Methicillin resistance was found in 66.7% of S.aureus and 79.2% of CoNS. ESBL ratio was 65% (26/40) for Klebsiella spp. and 67.9% (19/28) for E.coli. The frequency of resistance (%) to the main antimicrobial classes among the most prevalent isolates was summarized in Table 4 . Empirical antibiotic therapy was applied in 76.9% of the patients. Inappropriate antimicrobial therapy was determined in 42.4% (n=158) of the patients, and it was significantly higher in fatal cases (61.7%). In addition it was defined as an independent predictor of mortality (p = 0.000, OR: 3.81, 95% CI: 2.2-6.3) ( Table 5 ). The median length of time to appropriate antimicrobial therapy was 0 (0-3) day and there was no statistical difference between fatal and nonfatal groups. The mortality rate of the patients 14 days after BSIs was 37.8% (n=141). When the risk factors for mortality were evaluated in univariate analysis, older age (>65 years), ICU stay on the time of infection onset, presence of underlying condition, steroid usage, dialysis, hypothermia, inappropriate antimicrobial therapy, infections due to Acinetobacter spp. and Candida spp. were found as a significant risk factors for mortality (Table 2  and 3) . Logistic regression analysis revealed that, BSIs due to the Acinetobacter spp. and Candida spp. had 2.35 and 2.48 times higher mortality rates, respectively. Inappropriate antimicrobial therapy, presence of hypothermia, steroid usage, dialysis and two or more underlying conditions were other independent predictors for mortality (Table 5) .
Discussion
Bloodstream infections are the important causes of morbidity and mortality in nosocomial setting. Prevalence of BSIs, causative isolates and resistance patterns are different across the world 8 . For this reason, surveillance data should be evaluated carefully in order to start appropriate empirical antimicrobial therapy. There are different reports about the frequency of nosocomial infections.
invasive characteristics and resistance patterns of the Acinetobacter spp. had an impact on increased mortality rates. Since the MDR pattern reduces the count of effective antibiotic options, it is frequently related with poor outcome 21 . Appropriate antimicrobial therapy is crucial and is known to have a significant influence on decreasing the mortality of patients with BSI. In the present study, inappropriate antimicrobial therapy was determined as an independent predictor for mortality similar to previous studies 15, 22 . In conclusion, we found that Methicillin resistance was found 66.7% for S.aureus and 79.2% for CoNS. Inan et al. reported higher MRSA ratio (93.1%) previously 1 . ESBL comprised 67.9% of E.coli and 65% of Klebsiella spp., which were higher than the previous multicenter study in Turkey 18 . In addition, Acinetobacter spp. was usually resistant to the most of the antibiotics used empirically. In fact, multidrug resistance (MDR) rate of Acinetobacter spp. was 98.7% and carbapenem resistance was 94.7%, which is higher than the previous report of Yüce et al. 20 . We thought that infections due to the Acinetobacter spp. were predominant in patients with BSI. Because of the emergence of MDR isolates, it is becoming a clinical challenge to overcome these infections. Surveillance data should be evaluated carefully in nosocomial settings. The prevalent isolates and resistance patterns should be taken into account before starting empirical antimicrobial therapy, which is crucial to reduce mortality rate.
